<DOC>
	<DOCNO>NCT01181141</DOCNO>
	<brief_summary>The objective study evaluate safety efficacy DU-176b compare enoxaparin sodium prevention venous thromboembolism patient elective hip fracture surgery .</brief_summary>
	<brief_title>Study DU-176b , Prevention Venous Thromboembolism Patients After Hip Fracture Surgery</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Edoxaban</mesh_term>
	<mesh_term>Enoxaparin</mesh_term>
	<criteria>Subjects schedule undergo surgery within 10 day fracture inner out femoral neck ( trochanteric subtrochanteric ) Subjects risks hemorrhage Subjects thrombolic risk Subjects weigh less 40 kg Subjects pregnant suspect pregnancy , subject want become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Anticoagulants</keyword>
	<keyword>Enoxaparin sodium</keyword>
	<keyword>venous thromboembolism .</keyword>
	<keyword>thromboembolism</keyword>
	<keyword>Thrombosis</keyword>
	<keyword>deep vein thrombosis</keyword>
	<keyword>DU-176b</keyword>
	<keyword>Edoxaban</keyword>
	<keyword>factor Xa</keyword>
	<keyword>hip fracture surgery</keyword>
	<keyword>embolism</keyword>
</DOC>